Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01334281 · ClinicalTrials.gov registry record
An In-vitro Standardization of B Cell Elispot Assays
A clinical trial, sponsored by Northwestern University.
- Terminated
- Registry status
- 19
- Enrollment target
NCT01334281 is a clinical trial that was terminated before completion, run by Northwestern University. The registered enrollment target is 19 participants.
The verdict
NCT01334281 was terminated before completion, sponsored by Northwestern University.
- TERMINATED
- Registry status
- 19 participants
- Enrollment target
Study Summary
This study is being done because the study doctor is trying to develop a new test which will help transplant doctors monitor patients with high panel reactive antibodies (PRA). The test would be used to monitor patients' PRA when doctors are trying to lower it through a process known as desensitization. Desensitization lowers high PRA levels and allows patients to receive transplants. This is a single center study to evaluate and optimize the use of a new laboratory test to detect and measure the immune system's functioning.
Interventions
- PROCEDURE Blood Draw
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2008-02 |
| Est. Completion | 2012-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01334281
The ClinicalTrials.gov registry entry for NCT01334281 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Blood Draw is the first listed.
NCT01334281 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01334281 about?
NCT01334281 is a clinical study titled "An In-vitro Standardization of B Cell Elispot Assays". This study is being done because the study doctor is trying to develop a new test which will help transplant doctors monitor patients with high panel reactive antibodies (PRA). The test would be used to monitor patients' PRA when doctors are trying to lower it through a process known as desensitizat...
What is the current status of trial NCT01334281?
This trial is currently terminated. The enrollment target is 19 participants. The study started on 2008-02. Estimated completion is 2012-10.
What interventions are being tested in trial NCT01334281?
The interventions under investigation include: Blood Draw (PROCEDURE).
Who is sponsoring clinical trial NCT01334281?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.